Related Experiment Videos
Aortoiliac endarterectomy in young patients
J M Capdevila1, M A Marco-Luque, M A Cairols
1Servicio de Cirugia Vascular, Hospital de Bellvitge, Barcelona, Spain.
Annals of Vascular Surgery
|May 1, 1986
Summary
Aortoiliac thromboendarterectomy (TEA) is effective in young smokers with advanced atherosclerosis. This study found comparable long-term patency rates in younger versus older patients, supporting TEA use in this demographic.
Area of Science:
- Vascular Surgery
- Cardiovascular Research
- Surgical Outcomes
Background:
- Aortoiliac atherosclerosis commonly affects older individuals.
- Treatment options for young patients with advanced disease are less defined.
- Smoking is a significant risk factor for peripheral artery disease.
Purpose of the Study:
- To evaluate the efficacy and outcomes of aortoiliac thromboendarterectomy (TEA) in young patients.
- To compare TEA results in young versus older patient cohorts.
- To assess the impact of surgical approach (transperitoneal vs. retroperitoneal) on outcomes in young patients.
Main Methods:
- Retrospective analysis of 304 aortoiliac thromboendarterectomies (TEA) performed between 1976 and 1981.
- Specific focus on 47 TEA procedures in patients under 50 years of age.
- Comparison of patency rates, morbidity, and mortality between young and older patient groups, and between surgical approaches.
Main Results:
- Four-year patency rates for young patients were 78% (transperitoneal) and 79% (retroperitoneal).
- These rates were comparable to those in patients over 50 (85% and 82%, respectively).
- All young patients included in the study were smokers presenting with severe symptoms.
Conclusions:
- Aortoiliac thromboendarterectomy (TEA) is a viable and effective treatment for young patients with symptomatic advanced atherosclerosis.
- The study questions the previous notion of limiting TEA to localized lesions and suggests its broader application.
- Surgical approach and patient age did not significantly impact long-term patency in this cohort.